Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring bla_NDM and bla_OXA From Clinical Origin

References

• Hsu L-Y, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and southeast Asia. Clin Microbiol Rev. 2017;30(1):1–22. doi:10.1128/cmr.00042-1627795305
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478–482. doi:10.1016/j.apjtb.2017.01.019
   Web of Science ®Google Scholar
• Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, Blatt NL. World Health Organization report: current crisis of antibiotic resistance. BioNanoScience. 2019;9(4):778–788. doi:10.1007/s12668-019-00658-4
   Web of Science ®Google Scholar
• Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539.30988669
   PubMed Web of Science ®Google Scholar
• Qamar M, Lopes B, Hassan B, et al. The present danger of New Delhi metallo-β-lactamase: a threat to public health. Future Microbiol. 2020;15(18):1759–1778. doi:10.2217/fmb-2020-006933404261
   PubMed Web of Science ®Google Scholar
• CDC. Antibiotic resistance threats in the United States, 2019. Report. 2019.
   Google Scholar
• Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi:10.2147/IDR.S17386730349322
   PubMed Web of Science ®Google Scholar
• Khurshid M, Rasool MH, Siddique MH, et al. Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii. J Infect Dev Ctries. 2019;13(10):899–905. doi:10.3855/jidc.1141032084020
   PubMed Web of Science ®Google Scholar
• Qamar MU, Nahid F, Walsh TR, Kamran R, Zahra R. Prevalence and clinical burden of NDM-1 positive infections in pediatric and neonatal patients in Pakistan. Pediatr Infect Dis J. 2015;34(4):452–454. doi:10.1097/INF.000000000000058225764102
   PubMed Web of Science ®Google Scholar
• Qamar MU, Walsh TR, Toleman MA, et al. Dissemination of genetically diverse NDM-1, −5, −7 producing-gram-negative pathogens isolated from pediatric patients in Pakistan. Future Microbiol. 2019;14(8):691–704. doi:10.2217/fmb-2019-001231148474
   PubMed Web of Science ®Google Scholar
• Qamar MU, Saleem S, Toleman MA, et al. In vitro and in vivo activity of Manuka honey against NDM-1-producing Klebsiella pneumoniae ST11. Future Microbiol. 2018;13(1):13–26. doi:10.2217/fmb-2017-011929226698
   PubMed Web of Science ®Google Scholar
• Elbediwi M, Li Y, Paudyal N, et al. Global burden of colistin-resistant bacteria: Mobilized Colistin Resistance Genes Study (1980–2018). Microorganisms. 2019;7(10):461. doi:10.3390/microorganisms7100461
   Web of Science ®Google Scholar
• Qamar MU, Ejaz H, Walsh TR, et al. Clonal relatedness and plasmid profiling of extensively drug-resistant New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae clinical isolates. Future Microbiol. 2021;16(4):229–239. doi:10.2217/fmb-2020-031533625250
   PubMed Web of Science ®Google Scholar
• Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017;6(1):21. doi:10.1186/s13756-017-0180-528191309
   PubMed Web of Science ®Google Scholar
• Qamar MU, Saleem S, Arshad U, et al. Antibacterial efficacy of manuka honey against New Delhi metallo-β-lactamase producing gram negative bacteria isolated from blood cultures. Pak J Zool. 2017;49(6):1997–2003.
   Web of Science ®Google Scholar
• Weinstein MP, Patel JB, Campeau S, et al. Performance Standarad for Antimicrobial Suceptibility Testing. 28th ed. Clinical and Laboratory Standards Institute;2018.
   Google Scholar
• Qamar MU, Hannan A, Arshad MU, Arshad M. Metallo-β-lactamase producing Enterobacter cloacae: an emerging threat in neonates. Afr J Microbiol Res. 2014;8(6):525–528. doi:10.5897/AJMR2013.6348
   Google Scholar
• Javed H, Ejaz H, Zafar A, Rathore AW. Metallo-beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: a rising threat for hospitalized children. J Pak Med Assoc. 2016;66(9):1068–1072.27654721
   PubMed Web of Science ®Google Scholar
• Hsia Y, Lee BR, Versporten A, et al. Use of the WHO access, watch, and reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7(7):e861–e871. doi:10.1016/S2214-109X(19)30071-331200888
   PubMed Web of Science ®Google Scholar
• Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J Med Microbiol. 2014;63(1):50–55. doi:10.1099/jmm.0.063925-024085817
   PubMed Web of Science ®Google Scholar
• Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910. doi:10.2147/IDR.S23461031908502
   PubMed Web of Science ®Google Scholar
• El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A, Hetta HF. Antibiogram, prevalence of OXA carbapenemase encoding genes, and RAPD-genotyping of multidrug-resistant acinetobacter baumannii incriminated in hidden community-acquired infections. Antibiotics. 2020;9(9):603. doi:10.3390/antibiotics9090603
   Web of Science ®Google Scholar
• Rafei R, Pailhoriès H, Hamze M, et al. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using blaOXA-51-like sequence based typing. BMC Microbiol. 2015;15(1):103. doi:10.1186/s12866-015-0441-525976451
   PubMed Web of Science ®Google Scholar
• Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci. 2018;25(3):586–596. doi:10.1016/j.sjbs.2016.02.00929686523
   PubMed Web of Science ®Google Scholar
• Ayobami O, Willrich N, Harder T, Okeke IN, Eckmanns T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747–1759. doi:10.1080/22221751.2019.169827331805829
   PubMedGoogle Scholar
• Sileem AE, Said AM, Meleha MS. Acinetobacter baumannii in ICU patients: a prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality. Egypt J Chest Dis Tuberc. 2017;66(4):693–698. doi:10.1016/j.ejcdt.2017.01.003
   Web of Science ®Google Scholar
• Begum S, Hasan F, Hussain S, Ali Shah A. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pak J Med Sci. 2013;29(5):1253–1258. doi:10.12669/pjms.295.369524353731
   PubMed Web of Science ®Google Scholar
• Hadjadj L, Syed MA, Abbasi SA, Rolain J-M, Jamil B. Diversity of carbapenem resistance mechanisms in clinical gram-negative bacteria in Pakistan. Microb Drug Resist. 2020. doi:10.1089/mdr.2019.0387
   Web of Science ®Google Scholar
• Braun SD, Jamil B, Syed MA, et al. Prevalence of carbapenemase-producing organisms at the Kidney Center of Rawalpindi (Pakistan) and evaluation of an advanced molecular microarray-based carbapenemase assay. Future Microbiol. 2018;13(11):1225–1246. doi:10.2217/fmb-2018-008229938540
   PubMed Web of Science ®Google Scholar
• Abouelfetouh A, Torky AS, Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrob Resist Infect Control. 2019;8(1):185. doi:10.1186/s13756-019-0611-631832185
   PubMed Web of Science ®Google Scholar
• Antunes NT, Fisher JF. Acquired class D β-lactamases. Antibiotics (Basel). 2014;3(3):398–434. doi:10.3390/antibiotics303039827025753
   PubMedGoogle Scholar
• Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, −24/40 and −58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother. 2008;63(1):55–59. doi:10.1093/jac/dkn43418957398
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo P, Huang H, Huang Y, Wu Z, Liao K. Detection of co-harboring OXA-58 and NDM-1 carbapenemase producing genes resided on a same plasmid from an Acinetobacter pittii clinical isolate in China. Iran J Basic Med Sci. 2019;22(1):106–111. doi:10.22038/ijbms.2018.28934.699430944716
   PubMed Web of Science ®Google Scholar
• Werneck JS, Picão RC, Girardello R, et al. Low prevalence of blaOXA-143 in private hospitals in Brazil. Antimicrob Agents Chemother. 2011;55(9):4494–4495. doi:10.1128/AAC.00295-1121849571
   PubMed Web of Science ®Google Scholar
• Pérez-Oseguera Á, Castro-Jaimes S, Salgado-Camargo AD, et al. Complete genome sequence of a bla(OXA-58)-producing Acinetobacter baumannii strain isolated from a Mexican hospital. Genome Announc. 2017;5(36):e00949–17. doi:10.1128/genomeA.00949-1728883144
   PubMedGoogle Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054. doi:10.1128/AAC.00774-0919770275
   PubMed Web of Science ®Google Scholar
• Sartor AL, Raza MW, Abbasi SA, et al. Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrob Agents Chemother. 2014;58(9):5589–5593. doi:10.1128/AAC.02425-1424982081
   PubMed Web of Science ®Google Scholar
• Karah N, Khalid F, Wai SN, Uhlin BE, Ahmad I. Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan. Ann Clin Microbiol Antimicrob. 2020;19(1):2. doi:10.1186/s12941-019-0344-731941492
   PubMed Web of Science ®Google Scholar
• Ramoul A, Loucif L, Bakour S, Amiri S, Dekhil M, Rolain JM. Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria. J Glob Antimicrob Resist. 2016;6:136–141. doi:10.1016/j.jgar.2016.05.00327530856
   PubMed Web of Science ®Google Scholar
• Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT. Prevalence of OXA-type β-lactamase genes among carbapenem-resistant acinetobacter baumannii clinical isolates in Thailand. Antibiotics (Basel). 2020;9(12):864. doi:10.3390/antibiotics9120864
   Web of Science ®Google Scholar
• Kuo S-C, Huang W-C, Huang T-W, et al. Molecular epidemiology of emerging bla(OXA-23-like)- and bla(OXA-24-like)-carrying Acinetobacter baumannii in Taiwan. Antimicrob Agents Chemother. 2018;62(3):e01215–17. doi:10.1128/AAC.01215-1729311067
   PubMed Web of Science ®Google Scholar
• Nawfal Dagher T, Al-Bayssari C, Chabou S, et al. Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon. BMC Microbiol. 2019;19(1):29. doi:10.1186/s12866-019-1401-230710998
   PubMed Web of Science ®Google Scholar